The content on this site is intended for healthcare professionals only
Low-value practices in oncology contributing to financial toxicity
The past and future of breast cancer treatment—from the papyrus to individualised treatment approaches
(6/6) ASCO 2017: Round up of expert discussion on the latest in prostate cancer
(5/6) ASCO 2017: ASCO highlights in prostate cancer
(4/6) ASCO 2017: Expert discussion on the latest in prostate cancer
(3/6) ASCO 2017: STAMPEDE data
(2/6) ASCO 2017: LATITUDE data
(1/6) ASCO 2017: Introduction to Expert discussion on the latest in prostate cancer
Clinical potential of trastuzumab biosimilar CTP6
ASCO 2017: Round up
Updates in melanoma: Treating BRAF and brain metastases
Bendamustine for indolent lymphoma reduces relapse after 10 years
ShortHER trastuzumab treatment of HER2 breast cancer: 9 weeks v 1 year
T-VEC and checkpoint therapy for melanoma
Prevalence of homologous recombination deficiency among 53,000 tumour samples
Natural plant based balm antidote to severe nail toxicity during chemotherapy
Dacomitinib for EGFR positive lung cancer
New ALK inhibitor alectinib halts lung cancer growth more than a year longer than crizotinib, with fewer severe side effects
Treating advanced melanoma with ipilimumab and HF10
Ado-trastuzumab emtansine in patients with HER2 mutant lung cancers
Immunotherapy may slow the growth of malignant pleural mesothelioma
Immunotherapy for mesothelioma could be on the horizon
CAR T-cell therapy can be used to send multiple myeloma into lasting remission
Alectinib eclipses crizotinib for ALK positive lung cancer
Adding a second HER2 targeted medicine may lower chance of invasive breast cancer
Targeted sequencing in endocrine refractory breast cancer
Results from the APHINITY trial of two HER2 targeted agents with chemo
Treating BRCA breast cancer with PARP inhibition
Relieving spinal cord compression symptoms with a single radiation treatment
Implementing new health initiatives in low-resource environments
Halving duration of ADT for high risk prostate cancer patients
New personalised therapies for lung cancer
Findings of a phase I/II study of nivolumab in patients with virus-associated tumours
Nivolumab and ipilimumab for metastatic sarcoma
Selumetinib in children with recurrent or refractory low-grade glioma
Dose escalation results of ceritinib and nivolumab for ALK NSCLC
Phase III results of olaparib for BRCA breast cancer
Global health initiative oncology
Self-reporting symptoms online improves patient care, chemotherapy duration and survival
Tivantinib as second line therapy for high-MET HCC
9 weeks vs 1 year adjuvant trastuzumab in combination with chemotherapy
Global study sets new risk-based standard to personalise chemotherapy for colon cancer after surgery
Olaparib slows growth of BRCA-related metastatic breast cancer
Web-based system for self-reporting symptoms may help patients live longer
3 or 6 months adjuvant oxaliplatin for colorectal cancer
No link between pregnancy and breast cancer relapse
Cancer and caring in modern medicine
Pooled analysis of avelumab for metastatic urothelial carcinoma
Cancer and living meaningfully: the CALM intervention
'Conquer Fear' of disease recurrence
Screening for 508 genes in liquid biopsy to chart cancer evolution
Larotrectinib shows durable efficacy across diverse paediatric and adult cancers
Routine genomic testing is feasible, but only a subset of patients benefit
Molecular profiles and the future of adjuvant therapy
Pregnancy after breast cancer no associated with relapse risk
Delaying metastatic prostate cancer, improving survival with abiraterone
STAMPEDE trial: abiraterone for advanced prostate cancer reduces progression/deaths
Hypogonadism following cisplatin treatment of testicular cancer
Recent childhood cancer survivors face less chronic disease risk than previous decades
Steady decrease in severe health problems for childhood cancer survivors
Low testosterone after testicular cancer could be linked to chronic health problems
Single radiation treatment can sufficiently relieve spinal cord compression symptoms
Web-based remote therapy program improves quality of life and lowers distress after diagnosis
Easing distress in patients with cognitive therapy
Psychological intervention lowers fear of cancer recurrence
